Home›Stock Screener›Transpact Enterprises

Transpact Enterprises Share Price Today | Stock Price & Transpact Enterprises Share Screener

TRANSPACT Medical Equipment

Track the current Transpact Enterprises share price and stock price live with TickJournal's free stock screener. Check TRANSPACT 52-week performance for the annual price range and momentum. Use the Transpact Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Transpact Enterprises opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Transpact Enterprises Market Cap ₹3.88 Cr.
TRANSPACT P/E Ratio (TTM) -
Transpact Enterprises P/B Ratio 6.87
EPS (TTM) ₹2.08
Dividend Yield -
Debt to Equity 0.16
TRANSPACT 52 Week High -
Transpact Enterprises 52 Week Low -
Operating Margin -
Profit Margin -
TRANSPACT Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹1.00
Total Equity ₹1.00

Transpact Enterprises Share Price Chart

Track the current stock price of Transpact Enterprises with an interactive chart. Analyse TRANSPACT share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Transpact Enterprises stock quote in one place.

Transpact Enterprises Company Profile - Fundamental Screener

Screen Transpact Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRANSPACT shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Medical Equipment industry, and it trades under ISIN INE06YD01010.

Company Details

Classification

Sector Healthcare
Industry Medical Equipment
Sub-Sector Medical Equipment
Segment E

Identifiers and Leadership

ISIN INE06YD01010

Transpact Enterprises Balance Sheet Screener

Screen TRANSPACT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹1, down from ₹1 in 2025.

Latest statistics put total assets at ₹1 and shareholder funds at ₹1, with a leverage ratio of 0.16.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 1 1 1 1 1 1 1 1 1 0
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 1 1 0 1 1 1 1 0 1 0
Share Capital 0 0 0 0 0 0 0 0 0 0
Reserves & Surplus 0 0 0 0 0 0 1 0 0 0

Transpact Enterprises Income Statement Screener - Profit & Revenue Analysis

Screen Transpact Enterprises income statement and profit fundamentals. Analyze TRANSPACT quarterly results. Transpact Enterprises reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹0 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0

Operating Costs and Margins

EBITDA 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit % 0.00% 65.00% 50.00% 0.00% -8.00% -139.00% -196.00% 0.00% -28.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 0 0 0 0 0 0 0
EPS 0.00 2.08 0.23 -2.35 -1.70 -5.71 -1.66 -11.20 -10.55 0.00 0.00 0.00 0.00

Transpact Enterprises Cash Flow Screener - Liquidity Fundamentals

Screen TRANSPACT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 0 0 0 -1 0 -1 0 0 0
Investing Activities 0 0 0 0 0 0 0 0 0 0

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 1 0 0 0
Net Cash Flow 0 0 0 0 -1 0 0 0 0 0

Transpact Enterprises Shareholding Pattern Screener

See Transpact Enterprises shareholding pattern with promoter, FII, and DII holdings. Check Transpact Enterprises promoter holding and ownership changes for TRANSPACT on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 16.16%, foreign institutions 0.00%, domestic institutions 0.00% and the public 63.66%, spread across 122 shareholders.

The shareholder count was 122 in 2026-Mar, compared with 122 in 2026-Sept.

Item 2026-Mar 2026-Sept 2025-Mar 2025-Sept 2024-Mar 2024-Sept 2023-Mar 2023-Sept

Promoter Holding

Promoter Holding 16.16% 16.16% 16.16% 0.13% 18.23% 16.16% 32.63% 32.20%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 63.66% 53.19% 61.33% 66.37% 64.95% 54.35% 61.97% 53.40%
Other Holding 20.18% 30.65% 22.50% 33.49% 16.82% 29.49% 5.39% 14.40%
Shareholder Count 122 122 129 123 119 143 62 114

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Transpact Enterprises. Transpact Enterprises dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Transpact Enterprises.

Transpact Enterprises Stock Index Membership - Nifty & Sensex

See which indices include Transpact Enterprises stock. Check TRANSPACT index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Transpact Enterprises is not part of any tracked indices.
Only major market indices are tracked in our system.

Transpact Enterprises Market Events Screener - Corporate Actions

Get Transpact Enterprises corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Transpact Enterprises stock events that may affect TRANSPACT share price, along with derivatives, futures and options activity and sector gainers.

9 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.

It is followed by Quarterly Result Announcement dated May 30, 2026 and Quarterly Result Announcement dated November 14, 2025.

Announcement Date Record Date Event Type Information Price Impact
2026-09-29 2026-09-29 Annual General Meeting NA 5.00%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.00%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -18.50%
2025-09-29 2025-09-29 Annual General Meeting NA 8.83%
2025-09-04 2025-09-04 Quarterly Result Announcement NA 10.23%
2025-05-30 2025-05-30 Quarterly Result Announcement NA -0.63%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 0.93%
2024-09-25 2024-09-25 Annual General Meeting NA -2.63%
2024-04-12 2024-04-12 Extraordinary General Meeting NA -3.59%

Transpact Enterprises Competitors Screener - Peer Stocks Comparison

Screen TRANSPACT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Poly Medicure 15,718 51.67 1,995 13.43% 321 34.41
Tarsons Products 1,677 158.28 447 9.38% 14 43.65
Q-Line Biotech 1,395 26.32 347 7.89% 56 41.75
Laxmi Dental 1,000 32.82 286 18.15% 26 33.55
Hemant Surgical Industries 898 47.15 238 112.99% 18 60.38
Vasa Denticity 770 71.34 283 12.77% 10 49.82
Osel Devices 616 21.44 295 57.88% 29 38.56
Fabtech Technologies 589 11.94 431 28.40% 38 35.96
Prevest Denpro 486 22.55 77 14.31% 21 59.41
QMS Medical Allied Services 342 26.28 174 10.27% 12 49.00

Transpact Enterprises Company Announcements - News & Reports Screener

Screen TRANSPACT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 18, 2026.

The next most recent announcements are dated September 30, 2026 and September 29, 2026.

Date Update Actions
2026-10-18 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-30 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-29 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-24 Closure of Trading Window -
2026-09-10 Intimation Of Closure Of Register Of Members & Share Transfer Books For The 13Th Annual General Meeting (AGM) -
2026-09-05 Notice Of 13Th Annual General Meeting To Be Held On 29Th September 2026 At 04:00 P.M. -
2026-09-05 Reg. 34 (1) Annual Report. -
2026-09-04 Revised Outcome Of The Board Meeting Held On 4Th September 2026 At 06:00 P.M. -
2026-09-04 Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th September 2026 At 04:00 P.M. -
2026-09-01 Board Meeting Intimation for Board Meeting To Be Held On September 4 2026 At 06:00 P.M. -
2026-07-14 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-07-01 Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) -
2026-05-30 Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 30TH MAY 2026 -
2026-05-23 Board Meeting Intimation for Considering The Audited Financial Statements Of The Company For The Half Year And Financial Year Ended 31St March 2026. -
2026-04-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-01-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-11-14 Board Meeting Outcome for Board Meeting Outcome For Adoption Of Unaudited Financial Results For The Half Year Ended September 30 2025. -
2025-11-10 Board Meeting Intimation for Board Meeting To Be Held On Friday 14Th November 2025 At 04:00 P.M. -
2025-10-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-10-07 Shareholder Meeting / Postal Ballot-Outcome of AGM -

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 6.87. Market capitalisation stands at ₹3.88 Cr. The company operates in the Healthcare sector, in the Medical Equipment industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on October 25, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.